Detalles de la búsqueda
1.
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial.
Lancet Respir Med
; 10(8): 785-795, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35691295
2.
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults.
Med
; 3(11): 760-773.e5, 2022 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35998623
3.
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials.
Vaccine
; 40(31): 4220-4230, 2022 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35691871
4.
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial.
Lancet Reg Health Am
; 4: 100079, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34541571
Resultados
1 -
4
de 4
1
Próxima >
>>